Professional Documents
Culture Documents
Rochefort & Associés - General Overview - March 2021 - Acropolis
Rochefort & Associés - General Overview - March 2021 - Acropolis
General overview
March 2021
Table of contents
About us
• We are an independent boutique investment bank specialized in the areas of mergers & acquisitions (M&A) and fundraising.
• We are based in Paris and Beijing with widespread affiliated networks across Europe, North America, the Middle East and Asia.
• We advise our clients on the identification and implementation of equity capital transactions with the aim of building long-term
shareholder value.
• The advice we offer is independent, creative, discrete and directed towards the sole interest of our clients.
• Our team comes from a multitude of business sectors and geographical regions, providing us with versatile and multi-skilled
corporate advisory capabilities and allowing us to serve our clients on cross-border transactions.
• Although we have a generalist profile, we benefit from a specific expertise in Transportation, Industrial and TMT sectors.
• Our team is composed of around 30 industry professionals, having prior experience at, among other institutions, Citigroup, Messier Maris
& Associés, Bank of America Merrill Lynch, Credit Suisse, Lazard, Leonardo & Co., HSBC, Euronext, ABN Amro and Cathay Capital.
• In addition, our Senior Advisors bring strong sectoral expertise and provide access to their extensive networks.
• We have been involved in more than 200 closed transactions of all sizes worth over 40 billion euros.
A powerful, generalist team able to support our clients An extensive network around the world to create
in all their M&A concerns. transaction opportunities for our clients.
Sectoral coverage
Shanghai
Rochefort Advisory China Ltd
Hong Kong
With offices based on two continents and a worldwide network of partners offices and Senior Advisors, Rochefort & Associés is able to achieve a
wide geographic coverage.
Paul Bellavoine Eric Besson Alain Davezac Laurent Elbaz Rémi Lemay
Senior Advisor Senior Advisor Senior Advisor Senior Advisor Senior Advisor
Jean Leviol Robert Natali Mahtab Saboori Ali Sarmad George Waddell
Senior Advisor (China) Senior Advisor Senior Advisor Senior Advisor Senior Advisor
Executives
Enguerrand Rochefort Thomas Blondet Guillaume de La Hosseraye Ghislain de Murard Cédric Roesler Serge Vidal
Founding Partner Founding Partner Managing Partner (China) Senior Banker Senior Banker Senior Banker
Team
Simon Richet Alexandre Dorangeville Haofei Wu Julie Der Agobian Adrien Rolland
Vice-President (EMEA)1 Vice-President (China) Associate Analyst Senior Analyst Senior
Executive presentation
Enguerrand Rochefort - Founding Partner Thomas Blondet - Founding Partner Guillaume de La Hosseraye - Partner (China)
18 years of experience in investment banking in 15 years of experience in investment banking in 15 years in China including 3 years as an investment
France and worldwide France and worldwide banker
Cédric Roesler - Senior Banker Ghislain de Murard - Senior Banker Serge Vidal - Senior Banker
20 years of experience in consulting with a 35 years of experience in investment banking in 15 years of experience in investment banking in
specialization in the pharmaceutical and food France and worldwide with a specialization in stock France and worldwide
industry market operations
Financial advisor to Financial advisor to Financial advisor to Financial advisor to Financial advisor to
October
December 2019
2019 October 2019
December 2019 October 2019
November 2019 October 2019 October 2019
September 2019
Financial advisor to Financial advisor to Financial advisor to Financial advisor to Financial advisor to
in its fundraising with in its fundraising with in its strategic partnership and in the sale of minority
in its sale to
sale to interests to
Assignments In Progress
Sole financial advisor to Sole financial advisor to Sole financial advisor to Sole financial advisor to Sole financial advisor to
A listed Chinese A listed Chinese A leading Chinese An Asia based petfood A French F&B
pharmaceutical company Medtech company Beauty company company company in China
Acquisition of an
Acquisition of an European in its fundraising of in its fundraising of in its divestment
European pharma €20m €5-10m
pharma company (size confidential)
company
Status: Due diligence Initial Engagement Due diligence Initial Engagement Due Diligence
Ongoing JulyOctober
2019 2019 September 2018 October
March 2018 2019 March 2017
Financial Advisor to
Sole financial advisor to Sole financial advisor to Sole financial advisor to
Strategic review of the
A Waste to Energy Chinese market
greenfield project
in its acquisition of in its fundraising with in its fundraising with
Financing bridge
$10+m and Business
Angels